T he majority of human carcinomas show a loss of epithelial apical-basal polarity during the progression from benign to invasive carcinoma. Apical-basal polarity is often regarded as a gatekeeper against tumour development and metastasis 1,2 . Apicalbasal polarity is regulated by three major polarity complexes: the PAR, Crumbs and Scribble complexes [3] [4] [5] . The core PAR complex consists of PAR3, PAR6 and atypical PKCs (aPKCs) and is essential in defining the apical domain of an epithelial cell [6] [7] [8] . Binding between PAR6 and aPKCs, PKCζ or PKCι promotes aPKCs to adopt an active and signalling-competent conformation to phosphorylate their substrates 9 . The loss of PAR3 results in dissociation of the PAR complex and a loss of epithelial polarity 10-12 . PAR3 expression is frequently downregulated in the primary tumour of various carcinoma types 1,2,13 .
S.E., short exposure; L.E., long exposure. n = 3 independent experiments. g, TetON-Snai1 MECs and MEOs were treated with doxycycline for four days, followed by 10 μM MG132 for 4 h and analysed for SNAI1 and GAPDH by immunoblotting. The values indicate the signal intensity of SNAI1 relative to GAPDH. All of the immunofluorescence and western blot images shown represent one of three independent experiments. Scale bars, 25 μm. Error bars represent the s.d. The source data for the graphs can be found in Supplementary Table 3 and unprocessed blots in Supplementary Fig. 7 .
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TetON-Twist1 mice we previously generated 25 . Induction of TWIST1 in 3D MEOs and 2D MECs isolated from these TetON-Twist1 mice both resulted in EMT and single cell invasion ( Supplementary  Fig. 1b-d) , which is consistent with published data 30 . Together, these data show that in contrast to TWIST1, SNAI1 induction fails to promote EMT specifically in 3D polarized organoids. We then examined the SNAI1 mRNA and protein levels in 2D and 3D cultures. Doxycycline treatment induced SNAI1 mRNA to similar levels in 2D and 3D cultures (Fig. 1c ). However, a significantly lower level of SNAI1 protein was detected in MEOs compared with MECs ( Fig. 1d ). Consistent with this, SNAI1 protein was detectable in only very few epithelial cells in MEOs, whereas the majority of MECs expressed SNAI1 protein after doxycycline treatment (Fig. 1e) . In contrast, TWIST1 protein and mRNA could be easily detected in TetON-Twist1 MEOs as well as in TetON-Twist1 MECs ( Supplementary Fig. 1e,f) . These results show that despite potent induction of SNAI1 mRNA, SNAI1 protein levels failed to increase in 3D polarized MEOs.
We examined SnaiNAI1 protein degradation rates in 2D versus 3D cultures in the presence of cycloheximide. Interestingly, SNAI1 protein was remarkably unstable in MEOs with a half-life of around 20 min compared with >100 min in MECs ( Fig. 1f ). Treatment with the proteasome inhibitor MG132 increased the SNAI1 protein level in MEOs to a level similar to MECs ( Fig. 1g ). Together, these results show that SNAI1 protein stability is significantly reduced in 3D polarized MEOs, which might be responsible for the failure of SNAI1 to promote EMT.
Loss of apical-basal polarity increases SNAI1 stability in MEOs.
One major difference between 3D MEOs and 2D MECs is the apical-basal polarity. We therefore reasoned that polarity might directly regulate SNAI1 protein stability. Primary MEOs took three days to establish a hollow lumen and apical-basal polarity, as indicated by the presence of cortical F-actin and the PAR complex components PAR3 and PKCζ at the apical surface. In contrast, after one day of culture, the majority of MEOs were not polarized with filled lumen ( Fig. 2a and Supplementary Fig. 2a ). Induction of SNAI1 in these pre-polarized MEOs resulted in a significantly higher percentage of organoids undergoing EMT ( Fig. 2b) , as indicated by reduced E-cadherin-mediated adherens junctions, loss of laminin V-positive basement membrane and increased fibronectin expression compared with induction of SNAI1 in polarized MEOs ( Fig. 2c ). Furthermore, SNAI1 protein levels increased in prepolarized MEOs compared with polarized MEOs after doxycycline treatment ( Fig. 2c-e ), supporting a role for apical-basal polarity in regulating SNAI1 protein levels.
We also used a selective myosin light-chain kinase inhibitor (ML7) to disrupt apical-basal polarity in fully polarized MEOs, as previously reported 31, 32 . Notably, ML7 treatment disrupted apical-basal polarity, greatly increased the percentage of SNAI1positive cells in individual MEOs (Fig. 2f,g ) and increased the total SNAI1 protein level ( Fig. 2h ). Together, our results strongly indicate that apical-basal polarity negatively regulates SNAI1 protein stability.
aPKC-mediated SNAI1 phosphorylation promotes SNAI1 protein degradation. Previous studies reported that SNAI1 stability is regulated by the phosphorylation of SNAI1 protein by GSK3β 33, 34 . Treatment with a selective GSK3 inhibitor CHIR-99021 increased SNAI1 protein levels in 2D MECs and in 3D MEOs; however, the fold increases in the SNAI1 protein levels were similar in 2D MECs and 3D MEOs, and the SNAI1 protein level remained significantly lower in 3D MEOs compared with that in 2D MECs following GSK3β inhibition ( Supplementary Fig. 3a ). Together, these data suggest that GSK3β is not responsible for apical-basal polarityinduced SNAI1 degradation.
To uncover the unknown mechanisms regulating SNAI1 protein stability, we used protein modification prediction software packages to identify potential conserved phosphorylation sites on SNAI1. These analyses identified S249 as a candidate aPKC phosphorylation site ( Supplementary Fig. 3b ,c). Sequence alignment showed that the potential aPKC phosphorylation motif RMSLL is highly conserved from humans to Drosophila (Fig. 3a ). Atypical PKCs serve as core components of the PAR polarity complex that is essential for apical-basal polarity 35 . We therefore generated phosphodeficient S249A and phospho-mimetic S249E SNAI1 mutants to determine whether phosphorylation of S249 affects SNAI1 protein stability. Indeed, the steady-state levels of the S249E SNAI1 mutant protein were significantly lower than those of the wild-type (WT) or S249A mutant SNAI1 (Fig. 3b) ; in contrast, their mRNA levels were similar in 2D cultures of MCF10A cells without apical-basal polarity (Fig. 3c ). The S249E SNAI1 protein consistently displayed a shorter half-life compared with WT or S249A SNAI1 proteins ( Fig. 3d ). MG132 stabilized the S249E SNAI1 protein without affecting its mRNA level ( Fig. 3e,f ). Furthermore, compared with WT SNAI1 and S249A mutant protein, the S249E mutant protein was highly ubiquitinated in the absence or presence of MG132 ( Fig.  3g ), further supporting the notion that phosphorylation of SNAI1 at S249 promotes SNAI1 ubiquitination and proteasome-mediated protein degradation.
To directly test whether aPKCs could phosphorylate S249 on SNAI1, we performed an in vitro kinase assay, using a phopho-S249-specific SNAI1 antibody that we generated, and found that purified PKCζ could phosphorylate purified SNAI1 WT protein at S249. Importantly, S249 phosphorylation was inhibited in the presence of the aPKC-specific inhibitor PZ09 (ref. 36 ; Fig. 3h ). We next co-expressed SNAI1 and PKCζ with β-TrCP, the E3 ligase that is predicted to bind to the S249 region. Ubiquitination of SNAI1 was detected in cells co-expressing PKCζ and β-TrCP and was reversed by treatment with PZ09 ( Fig. 3i ). Furthermore, we tested the SNAI1-6AS mutant in which all GSK3β-phosphorylation sites are abolished 34 and found that this mutant is as responsive to aPKC-mediated SNAI1 degradation as the WT SNAI1 protein ( Supplementary Fig. 3d ). These results show that phosphorylation of SNAI1 at S249 by aPKCs reduces SNAI1 protein stability, which is independent of GSK3-mediated SNAI1 phosphorylation.
We next expressed Tet-inducible SNAI1 WT and S249 mutants in polarized MEOs by lentiviral infection. Using a lentiviral construct carrying green fluorescent protein (GFP), we determined that our primary organoid infection reached about 35% of cells in individual organoids ( Supplementary Fig. 2b ). Similar to what we observed in TetON-Snai1 MEOs, the majority of organoids overexpressing WT SNAI1 and the S249E mutant failed to undergo EMT and invasion following doxycycline induction; in contrast, the S249A mutant was able to induce EMT and invasion in more than 65% of polarized organoids ( Fig. 4a,b ). The S249A mutant, but not WT and S249E SNAI1, consistently showed higher protein expression in MEOs without affecting SNAI1 mRNA levels ( Fig. 4c,d ). Together, these data suggest that apical-basal polarity regulates S249 phosphorylation to impact SNAI1 protein degradation and EMT.
The PAR3-aPKC complex is required for apical-basal polarity-induced SNAI1 protein degradation. To determine whether aPKC kinase activity is required for SNAI1 protein degradation in polarized MEOs, we treated TetON-Snai1 MEOs with PZ09, which inhibits both PKCζ and PKCι. In MEOs with intact apical-basal polarity, PKCζ and PAR3 could be detected at the apical region, as marked by strong cortical F-actin signals (Fig. 4e ). Importantly, induction of SNAI1 in the presence of PZ09 effectively promoted EMT in more than 80% of the MEOs, compared with activation of EMT in less than 15% MEOs in the control group (Fig. 4e,f ). Furthermore, PZ09 treatment drastically increased SNAI1 protein Supplementary Table 3 and unprocessed blots in Supplementary Fig. 7 . The alignment was generated by Clustal Omega. *, conserved sequence; :, conservative mutation; ., semi-conservative mutation. b, Immunoblot for SNAI1 and GAPDH in MCF10A cells expressing WT, and phospho-deficient S249A and phospho-mimetic S249E mutant SNAI1. The values indicate the signal intensity of SNAI1 relative to GAPDH. n = 3 independent experiments. c, qPCR analysis of relative SNAI1 mRNA levels normalized to GAPDH in MCF10A cells expressing WT, and phospho-deficient S249A and phospho-mimetic S249E SNAI1 mutants. Unpaired two-tailed Student's t-test with Welch's correction; n = 3 independent experiments. d, MCF10A cells expressing the indicated SNAI1 constructs were treated with 10 μM cycloheximide for the indicated time points and analysed for SNAI1 and GAPDH by immunoblotting (top). The graph represents the relative SNAI1 proteins levels (bottom). n = 3 independent experiments. e, MCF10A cells expressing the indicated SNAI1 constructs were treated with 10 μM MG132 for 4 h and the SNAI1 protein levels were analysed by immunoblotting. The values indicate the signal intensities of SNAI1 relative to GAPDH. f, qPCR analysis of relative SNAI1 mRNA levels normalized to GAPDH in MCF10A cells expressing the indicated SNAI1 constructs in the presence of MG132. Paired two-tailed Student's t-test; n = 3 independent experiments. g, SNAI1 proteins were immunoprecipitated from MCF10A cells expressing the indicated SNAI1 constructs with or without MG132 treatment and probed for SNAI1 and ubiquitin. Input, whole cell lysate. h, In vitro kinase assay for phospho (p)-SNAI1(S249) with purified WT and S249A SNAI1, and aPKC with or without PZ09 treatment. EV, empty vector. i, 293T cells overexpressing SNAI1, aPKC and β-TrCP in the indicated combinations were treated with either 5 μM PZ09 or dimethylsulfoxide (DMSO). SNAI1 proteins were immunoprecipitated from 293T cells and probed for ubiquitin, p-SNAI1(S249), SNAI1 and GAPDH. In g and i, IgG represents the isotype control. All of the immunofluorescence images and western blots shown represent one of three independent experiments. Error bars represent the s.d. The source data for the graphs can be found in Supplementary Table  3 and unprocessed blots in Supplementary Fig. 7 . Supplementary Table 3 and unprocessed blots in Supplementary Fig. 7 . levels (Fig. 4h ). Treatment of MEOs with PZ09 consistently resulted in a significant increase in the percentage of SNAI1-positive cells in individual organoids ( Fig. 4g-i) . Our results suggest that aPKC kinase activity is required for SNAI1 phosphorylation and degradation in polarized MEOs.
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We next expressed short hairpin RNAs (shRNA) against PAR3 by lentiviral infection of primary MEOs isolated from the TetON-Snai1 mice. Partial knockdown of PAR3 caused the loss of apical-basal polarity in certain areas of MEOs and mislocalization of PKCζ from the apical area (Fig. 5a ). Functionally, knockdown of PAR3 synergized with the induction of SNAI1 to promote EMT in MEOs (Fig. 5b) .
Importantly, knockdown of PAR3 increased the percentage of SNAI1-positive cells in individual MEOs (Fig. 5c,d) . Together, these data demonstrate that the PAR complex is required for aPKC-regulated SNAI1 destabilization to prevent EMT in polarized MEOs.
The PAR3-aPKC complex destabilizes endogenous SNAI1 protein to prevent EMT. We next investigated endogenous human SNAI1 regulation by polarity using Caco2 human intestinal epithelial cells that express endogenous SNAI1 mRNA and develop wellestablished apical-basal polarity in 3D (ref. 37 ). The endogenous SNAI1 protein level was consistently and significantly reduced in Supplementary Table 3 and unprocessed blots in Supplementary Fig. 7 . Supplementary Table 3 .
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3D polarized organoids compared with sparse 2D cultures without polarity. Immunoprecipitated endogenous SNAI1 protein is specifically phosphorylated at S249, is ubiquitinated and interacts with β-TrCP only in polarized 3D organoids, but not in 2D cultures ( Supplementary Fig. 4a ). PAR3 and aPKC proteins were specifically localized at the apical membrane in control organoids, whereas knockdown of PAR3 completely disrupted apical-basal polarity and caused mislocalization of aPKCs (Fig. 6a) . In control organoids, SNAI1 protein was largely undetectable; following knockdown of PAR3, most cells in individual organoids became positive for endogenous SNAI1 protein (Fig. 6a ). SNAI1 protein rapidly degraded with a half-life of <10 min in control organoids, whereas PAR3 knockdown elongated the half-life of SNAI1 to more than 80 min (Fig. 6b ). PAR3 knockdown consistently increased endogenous SNAI1 levels without affecting SNAI1 mRNA levels ( Fig. 6c and Supplementary Fig. 4b ). SNAI1 immunoprecipitated from Caco2 organoids is phosphorylated on S249 and interacts with both PAR3 and β-TrCP. Interestingly, both aPKC members (PKCζ and PKCι) are associated with SNAI1 in the control organoids. Importantly, knockdown of PAR3 abolished S249 phosphorylation on SNAI1 and significantly reduced the interaction between SNAI1 and aPKCs or β-TrCP (Fig. 6c ). Consequently, more than 80% of the organoids in 3D culture underwent EMT following knockdown of PAR3, as immunostaining showed reduced E-cadherin-mediated junctions, loss of laminin V and increased fibronectin expression ( Fig. 6d,e ). Importantly, PAR3 loss-induced EMT and invasion through the basement membrane could be significantly blocked following the deletion of SNAI1 despite polarity loss caused by PAR3 knockdown (Fig. 6d,e and Supplementary Fig. 4c ). These data strongly support a critical role of the PAR complex in reducing endogenous SNAI1 protein stability and blocking SNAI1-induced EMT.
We next investigated whether inactivation of aPKCs affects endogenous SNAI1 phosphorylation of S249 and subsequent degradation in Caco2 3D organoids. PZ09 effectively inhibited the aPKC kinase activity in Caco2 3D organoids, as assessed using an aPKC-specific fluorescence resonance energy transfer reporter 38 ( Supplementary Fig. 5a ). Morphologically, following PZ09 treatment, more than 90% of the Caco2 organoids lost apical-basal polarity, E-cadherin-mediated adherens junctions, basement membrane integrity and increased fibronectin expression, which is consistent with increases of SNAI1-positive cells (Fig. 7a,b and Supplementary  Fig. 5c ). Inhibition of aPKC kinase activity also increased SNAI1 protein levels and led to the expression of SNAI1 by the majority of cells in individual organoids without affecting SNAI1 mRNA levels ( Supplementary Fig. 5b-d) . The half-life of SNAI1 protein was increased from <10 min to >100 min following inhibition of aPKCs (Fig. 7c) . Notably, we found that endogenous SNAI1 protein is phosphorylated at S249, ubiquitinated, interacts with β-TrCP and all of these events were inhibited by PZ09 treatment (Fig. 7d ). We next investigated whether endogenous SNAI1 protein is required for the induction of EMT following aPKC inhibition in Caco2 organoids. Knockdown of SNAI1 significantly blocked EMT induction in response to PZ09 treatment (Fig. 7a,b and Supplementary Fig. 5d ), suggesting that inhibition of aPKC kinase activity promotes EMT in a SNAI1-dependent manner.
We next examined the individual contributions of PKCζ and PKCι. Although single knockdown of PKCζ or PKCι could partially stabilize SNAI1 and promote EMT in some organoids, only double knockdown of both PKCζ and PKCι could fully recapitulate the EMT and invasion phenotype induced by PZ09 treatment (Fig.  7e-g and Supplementary Fig. 5e,f) , which suggests that PKCζ and PKCι have redundant roles in the PAR complex to phosphorylate SNAI1 at S249. These data strongly indicate that both aPKC members in the PAR complex are responsible for the S249 phosphorylation of endogenous SNAI1 protein and subsequent ubiquitination and degradation of the SNAI1 protein. Together, these findings demonstrate that apical-basal polarity promotes endogenous SNAI1 protein phosphorylation and degradation via active aPKCs in the PAR complex to prevent EMT.
Loss of the PAR-complex-mediated polarity promotes invasion and metastasis via SNAI1 in vivo.
We implanted GFP-labelled Caco2 cells expressing control shRNA, shRNAs against PAR3 and shRNAs against PAR3 and SNAI1 in mice to follow the development and metastasis of primary tumours. Control Caco2 cells developed primary tumours that presented an epithelial morphology. In contrast, the loss of PAR3 resulted in mesenchymal primary tumours with very low membranous E-cadherin, high human vimentin and high SNAI1 expression. More importantly, knockdown of SNAI1 reversed the mesenchymal phenotype in Caco2 tumours expressing shRNAs against PAR3 (Fig. 8a,b and Supplementary Fig. 6a ). Consistent with the results in Fig. 6 , Caco2 control tumours were largely negative for SNAI1 immunostaining, whereas the knockdown of PAR3 increased SNAI1 protein expression ( Fig. 8b) . Moreover, mice carrying PAR3-knockdown tumours presented significantly more circulating tumour cells compared with mice carrying the control Caco2 tumours and the knockdown of SNAI1 significantly reduced circulating tumour cell numbers to that of the control (Fig. 8c ). Furthermore, we observed a significant increase in GFP-positive disseminated tumour cells in the lungs of mice carrying PAR3-knockdown tumours compared with controls and this increase in lung dissemination was completely blocked by SNAI1 knockdown (Fig. 8d,e ). These in vivo results strongly support our cellular and biochemical data showing that the PAR-complex-mediated SNAI1 protein degradation inhibits EMT, tumour invasion and metastasis in vivo.
PAR3 and SNAI1 expression are negatively correlated in human breast tissue samples. We next evaluated the involvement of the PAR3-SNAI1 regulatory mechanism in human breast cancer initiation and progression by immunostaining analysis for PAR3 and SNAI1 expression in human breast tissue microarray (TMA). PAR3 protein was detected at the apical membrane in normal mammary ducts and in the majority of ductal intraepithelial neoplasia samples, whereas expression of these proteins was clearly decreased in invasive ductal carcinoma samples. The reverse was observed for SNAI1, where SNAI1 protein was largely undetectable in normal and ductal intraepithelial neoplasia samples and was only evident in invasive ductal carcinoma samples ( Fig. 8f and Supplementary  Fig. 6b ). We next analysed PAR3 and SNAI1 expression in a cohort of 371 Stage 2 breast tumours from the NCI Cancer Diagnosis Program. Consistent with a suppressive function of the PAR epithelial polarity complexes on SNAI1 stability, 92% of the SNAI1positive tumours were negative for PAR3 ( Fig. 8g,h) . It is important to note that SNAI1 expression is regulated at the transcriptional and post-translational levels. This is consistent with Fig. 8h , which shows that among the 297 PAR3-negative tumours, 61 were positive for SNAI1, whereas the remaining 80% were still negative for SNAI1, possibly due to the lack of SNAI1 mRNA expression. Our results suggest that the molecular machinery that links the PAR3 complex with SNAI1 protein stability may also contribute to human breast tumour progression.
Discussion
We demonstrate that apical-basal polarity directly impinges on the EMT program to prevent EMT and invasion, thus inhibiting metastasis. Mechanistically, we show that under intact polarity, active aPKCs in the PAR complex phosphorylate SNAI1 at S249, which in turn promotes ubiquitination and degradation of the SNAI1 protein. Inactivation of the PAR3-aPKC polarity machinery stabilizes SNAI1 protein, thus promoting SNAI1-induced EMT and invasion. In vivo, the aPKC-mediated phosphorylation of SNAI1 hampers the ability of SNAI1 to promote breast tumour cells to invade, disseminate and metastasize to distant organs. The downregulation of PAR3 and increase in SNAI1 protein expression are associated with breast tumour progression in human breast cancer patients. Our findings reveal a direct molecular link between apical-basal polarity and the core EMT transcription machinery in tumour invasion and metastasis ( Supplementary Fig. 6c ).
Previous studies of EMT regulation of epithelial cell properties focused on cell-cell junctions, such as tight junctions and adherens junctions 22 . Although loss of cell polarity is an early step during the EMT process, polarity is largely thought to be a passive recipient of the EMT-inducing signals to decrease epithelial characteristics. The results from this study show that apical-basal polarity actively inhibits the core EMT transcriptional program by destabilizing the SNAI1 protein. Given the key role of SNAI1 in suppressing proteins that are associated with cell-cell junctions 33, 39 , our results introduce the concept that apical-basal polarity is actively involved in maintaining epithelial cell-cell junctions by suppressing the EMT program. Importantly, our study also demonstrates that polarity is a critical checkpoint during EMT. A number of key EMT transcription factors, particularly SNAI1 and ZEB1, have been shown to suppress transcription of several key polarity genes, including Crb3, PATj and LGL2, thus disrupting apical-basal polarity 22, [40] [41] [42] . Consequently, the loss of epithelial polarity sends a positive feedback signal to further stabilize SNAI1 and move the EMT process forwards to promote tumour progression ( Supplementary Fig. 6c ). The majority of human carcinomas show a loss of apical-basal polarity during the progression from intraepithelial neoplasia to invasive carcinoma [43] [44] [45] . Our work (and several previous studies) links epithelial cell polarity proteins, such as PAR3 and aPKCs, to metastasis suppression 2 . The loss of PAR3 promotes cancer metastasis through the activation of Tiam1-mediated Rac-GTP pathway and inhibition of E-cadherin junction stability 12 . In addition, loss of PAR3 accelerates breast cancer formation and metastasis through aPKC-mediated Jak-Stat3 signalling 10 . This study adds SNAI1 as a key target of the PAR-aPKC polarity complex in suppressing tumour invasion and metastasis. Together, these findings support the idea that epithelial cell polarity proteins function as major metastasis suppressors through several pathways to maintain epithelial characteristics in carcinomas.
SNAI1 stability is also regulated by phosphorylation of the SNAI1 protein by GSK3β 33, 34 . Our study shows that inhibiting GSK3 under both polarized and unpolarized conditions stabilized the SNAI1 protein to the same degree. These data show that GSK3 inhibition cannot rescue polarity-mediated SNAI1 degradation and that GSK3 promotes SNAIl degradation regardless of the polarity status. SNAI1 could therefore be regulated by diverse upstream signals independently to regulate its stability to impact EMT.
Our data identify an unexpected role for aPKCs in suppressing EMT, thus inhibiting tumour invasion and metastasis. Previous studies suggest that aPKCs may promote tumour proliferation and progression 10, [46] [47] [48] [49] . However, these studies were largely performed in cells that lack apical-basal polarity and may thus reflect polarityindependent functions of aPKCs. For example, in addition to their function in the PAR complex, aPKCs also bind to another scaffold protein p62 to function in response to tumour necrosis factor α, lipopolysaccharide and interleukin-1 (ref. 50 ). It is therefore critical to analyse aPKCs under specific physiological conditions to reveal the diverse roles of this unique PKC subfamily in tumour progression and metastasis.
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